Concurrent chemotherapy and pulsed high-intensity focused ultrasound therapy for the treatment of unresectable pancreatic cancer: initial experiences.

PubWeight™: 0.94‹?›

🔗 View Article (PMC 3052608)

Published in Korean J Radiol on March 03, 2011

Authors

Jae Young Lee1, Byung Ihn Choi, Ji Kon Ryu, Yong-Tae Kim, Joo Ha Hwang, Se Hyung Kim, Joon Koo Han

Author Affiliations

1: Department of Radiology and the Institute of Radiation Medicine, Seoul National University Hospital, Seoul 110-744, Korea.

Associated clinical trials:

Concurrent FOLFIRINOX Plus High Intensity Focused Ultrasound for Pancreatic Cancer | NCT05262452

Articles cited by this

Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer. J Clin Oncol (2009) 5.11

Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group. J Clin Oncol (2007) 4.68

Pulsed-high intensity focused ultrasound and low temperature-sensitive liposomes for enhanced targeted drug delivery and antitumor effect. Clin Cancer Res (2007) 2.17

Feasibility of US-guided high-intensity focused ultrasound treatment in patients with advanced pancreatic cancer: initial experience. Radiology (2005) 2.12

Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas. Ann Surg Oncol (2001) 2.01

Pulsed high-intensity focused ultrasound enhances apoptosis and growth inhibition of squamous cell carcinoma xenografts with proteasome inhibitor bortezomib. Radiology (2008) 1.82

Pathological changes in human malignant carcinoma treated with high-intensity focused ultrasound. Ultrasound Med Biol (2001) 1.78

Concurrent gemcitabine and high-intensity focused ultrasound therapy in patients with locally advanced pancreatic cancer. Anticancer Drugs (2010) 1.27

Early clinical experience using high intensity focused ultrasound for palliation of inoperable pancreatic cancer. JOP (2009) 1.23

Preclinical in vivo evaluation of an extracorporeal HIFU device for ablation of pancreatic tumors. Ultrasound Med Biol (2009) 1.20

Complications of high intensity focused ultrasound in patients with recurrent and metastatic abdominal tumors. World J Gastroenterol (2007) 1.19

High-intensity focused ultrasound therapy: an overview for radiologists. Korean J Radiol (2008) 0.98

Complications of high intensity focused ultrasound for patients with hepatocellular carcinoma. Technol Cancer Res Treat (2009) 0.92

Gemcitabine chemotherapy versus 5-fluorouracil-based concurrent chemoradiotherapy in locally advanced unresectable pancreatic cancer. Pancreas (2006) 0.91

The effect of endostatin and gemcitabine combined with HIFU on the animal xenograft model of human pancreatic cancer. Biomed Pharmacother (2009) 0.90

A phase II trial of gemcitabine plus capecitabine for patients with advanced pancreatic adenocarcinoma. Cancer Chemother Pharmacol (2007) 0.88

Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas: great logic, grim reality. Ann Surg Oncol (2001) 0.82

Influence of the docetaxel administration period (neoadjuvant or concomitant) in relation to HIFU treatment on the growth of Dunning tumors: results of a preliminary study. Prostate Cancer Prostatic Dis (2007) 0.79

Articles by these authors

Consensus statement on the pathology of IgG4-related disease. Mod Pathol (2012) 9.01

Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int (2010) 5.02

Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum (2012) 4.27

Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach. Gastrointest Endosc (2008) 3.43

Complications of ERCP. Gastrointest Endosc (2012) 2.61

Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut (2012) 2.52

The role of endoscopy in the management of variceal hemorrhage. Gastrointest Endosc (2014) 2.47

Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver - update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med Biol (2012) 2.39

Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology (2009) 2.25

The management of antithrombotic agents for patients undergoing GI endoscopy. Gastrointest Endosc (2015) 2.23

Esophageal varices in patients with cirrhosis: multidetector CT esophagography--comparison with endoscopy. Radiology (2007) 2.21

The role of endoscopy in the management of premalignant and malignant conditions of the stomach. Gastrointest Endosc (2015) 2.19

Complications of colonoscopy. Gastrointest Endosc (2011) 2.12

ASGE Technology Committee systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting real-time endoscopic assessment of the histology of diminutive colorectal polyps. Gastrointest Endosc (2015) 2.11

The role of endoscopy in the evaluation and management of dysphagia. Gastrointest Endosc (2013) 2.10

Electronic chromoendoscopy. Gastrointest Endosc (2014) 2.10

Small (<or=3 cm) solid pseudopapillary tumors of the pancreas at multiphasic multidetector CT. Radiology (2010) 2.04

MicroRNA miR-155 is a biomarker of early pancreatic neoplasia. Cancer Biol Ther (2009) 2.01

The role of endoscopy in Barrett's esophagus and other premalignant conditions of the esophagus. Gastrointest Endosc (2012) 2.01

Informatics in radiology: dual-energy electronic cleansing for fecal-tagging CT colonography. Radiographics (2013) 1.97

Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer. PLoS One (2010) 1.96

Multicenter analysis of clinicopathologic features of intraductal papillary mucinous tumor of the pancreas: is it possible to predict the malignancy before surgery? Ann Surg Oncol (2005) 1.95

Imaging of subsquamous Barrett's epithelium with ultrahigh-resolution optical coherence tomography: a histologic correlation study. Gastrointest Endosc (2009) 1.92

A comparison of covered and uncovered Wallstents for the management of distal malignant biliary obstruction. Gastrointest Endosc (2006) 1.90

High-intensity focused ultrasound: current potential and oncologic applications. AJR Am J Roentgenol (2008) 1.86

Differential diagnostic and staging accuracies of high resolution ultrasonography, endoscopic ultrasonography, and multidetector computed tomography for gallbladder polypoid lesions and gallbladder cancer. Ann Surg (2009) 1.85

Small (≤ 20 mm) pancreatic adenocarcinomas: analysis of enhancement patterns and secondary signs with multiphasic multidetector CT. Radiology (2011) 1.84

Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. Radiology (2014) 1.78

Intussusception in adults: from stomach to rectum. AJR Am J Roentgenol (2004) 1.77

MR imaging features of small solid pseudopapillary tumors: retrospective differentiation from other small solid pancreatic tumors. AJR Am J Roentgenol (2010) 1.75

Adverse events of upper GI endoscopy. Gastrointest Endosc (2012) 1.72

Ectopic pancreas: CT findings with emphasis on differentiation from small gastrointestinal stromal tumor and leiomyoma. Radiology (2009) 1.69

Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma. Pancreas (2008) 1.67

Clonorchiasis and cholangiocarcinoma: etiologic relationship and imaging diagnosis. Clin Microbiol Rev (2004) 1.65

Value of contrast-enhanced sonography for the characterization of focal hepatic lesions in patients with diffuse liver disease: receiver operating characteristic analysis. AJR Am J Roentgenol (2005) 1.65

Endoscopic submucosal dissection. Gastrointest Endosc (2015) 1.62

Attenuation-based automatic tube voltage selection and tube current modulation for dose reduction at contrast-enhanced liver CT. Radiology (2012) 1.59

Two- versus three-dimensional colon evaluation with recently developed virtual dissection software for CT colonography. Radiology (2007) 1.58

Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy. Radiology (2009) 1.56

The role of endoscopy in the management of acute non-variceal upper GI bleeding. Gastrointest Endosc (2012) 1.53

Hepatocellular carcinoma in liver transplantation candidates: detection with gadobenate dimeglumine-enhanced MRI. AJR Am J Roentgenol (2008) 1.52

The role of endoscopy in the patient with lower GI bleeding. Gastrointest Endosc (2014) 1.51

Radiofrequency ablation of the porcine liver in vivo: increased coagulation with an internally cooled perfusion electrode. Acad Radiol (2006) 1.50

To perform a biopsy or not to perform a biopsy? Does confocal endomicroscopy provide the answer for surveillance in Barrett's esophagus? Gastrointest Endosc (2009) 1.48

Bipolar radiofrequency ablation in ex vivo bovine liver with the open-perfused system versus the cooled-wet system. Eur Radiol (2004) 1.45

The hepatic regeneration power of mild steatotic grafts is not impaired in living-donor liver transplantation. Liver Transpl (2005) 1.45

Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging. Invest Radiol (2010) 1.44

A pilot study of in vivo identification of pancreatic cystic neoplasms with needle-based confocal laser endomicroscopy under endosonographic guidance. Endoscopy (2013) 1.42

[Natural history of branch-duct type intraductal papillary mucinous neoplasms of the pancreas]. Korean J Gastroenterol (2007) 1.41

Does endoscopic sphincterotomy reduce the recurrence rate of cholangitis in patients with cholangitis and suspected of a common bile duct stone not detected by ERCP? Gastrointest Endosc (2007) 1.40

Comment on "Deformation of biological cells in the acoustic field of an oscillating bubble". Phys Rev E Stat Nonlin Soft Matter Phys (2010) 1.37

Cyst growth rate predicts malignancy in patients with branch duct intraductal papillary mucinous neoplasms. Clin Gastroenterol Hepatol (2010) 1.35

Intrapancreatic accessory spleen: findings on MR Imaging, CT, US and scintigraphy, and the pathologic analysis. Korean J Radiol (2008) 1.34

High-resolution OCT balloon imaging catheter with astigmatism correction. Opt Lett (2009) 1.30

Macrocystic neoplasms of the pancreas: CT differentiation of serous oligocystic adenoma from mucinous cystadenoma and intraductal papillary mucinous tumor. AJR Am J Roentgenol (2006) 1.29

Acoustic radiation force impulse elastography for the evaluation of focal solid hepatic lesions: preliminary findings. Ultrasound Med Biol (2009) 1.28

The role of endoscopy in the management of choledocholithiasis. Gastrointest Endosc (2011) 1.28

Adverse events associated with EUS and EUS with FNA. Gastrointest Endosc (2013) 1.27

Diagnostic accuracy of T and N stages with endoscopy, stomach protocol CT, and endoscopic ultrasonography in early gastric cancer. J Surg Oncol (2009) 1.26

Focal peliosis hepatis as a mimicker of hepatic tumors: radiological-pathological correlation. J Comput Assist Tomogr (2007) 1.25

Differentiation between biliary cystic neoplasms and simple cysts of the liver: accuracy of CT. AJR Am J Roentgenol (2010) 1.25

Korean guidelines for colorectal cancer screening and polyp detection. Clin Endosc (2012) 1.25

Accuracy of preoperative T-staging of gallbladder carcinoma using MDCT. AJR Am J Roentgenol (2008) 1.23

Early clinical experience using high intensity focused ultrasound for palliation of inoperable pancreatic cancer. JOP (2009) 1.23

Intrahepatic mass-forming cholangiocarcinomas: enhancement patterns at multiphasic CT, with special emphasis on arterial enhancement pattern--correlation with clinicopathologic findings. Radiology (2011) 1.23